with Continuous Mobility Assessment
Speaker: Alexis Mathieu | Company: FeetMe | Date: 13-14 October 2021 | Full Presentation
Bringing a drug to market is long and difficult. Studies estimate that the clinical trial process lasts 9 years and costs $1.3B on average. Clinical trials are conducted in multiple phases, with cost and complexity increasing from Phase I to Phase III. Despite the time and capital invested in trials, only 1 in 10 drugs that enter Phase I of a clinical trial will be approved by the FDA.
There is Large medical need to evaluate to treat the physical deterioration of physical status. A growing number of patients with mobility impairments lacks accurate tools to diagnose, monitor expensive evolutive diseases and intervene efficiently.
Gait is the simplest and most actionable biomarker to monitor multiple diseases but vastly underutilized as a biomarker or outcome measure because gait analysis is often not high quality when assessed in the clinic.Clinical gait tests, today, are used to identify mobility disorders, measure the efficacy of a therapeutic treatment. This is done in a controlled setting at sites. However, the technologies or design used present strong limitations. Episodic assessments, sometimes observational, don't generate sufficient sensitive data to demonstrate subtle changes.
The FeetMe solution allows the collection of validated gait data at site with the Insoles, and in the same accurate way in the patients daily life allowing continuous recording of gait data.
Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs)
portfolio of expert led masterclass year-round platform
And do NOT miss our flagship event in Berlin on 17-18 OCT 2023 focused on Reshaping the Future of Electronics. This event attracts 550-600 participants from all the world and offers a superb ambience and dynamic exhibition floor.
To learn more visit
https://www.techblick.com/electronicsreshaped
To see feedback about previous event see https://www.techblick.com/events-agenda
Comments